Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?

Ayhan, A; Taskiran, C; Celik, C; Guney, I; Yuce, K; Ozyar, ENİS; Atahan, L; Kucukali, T

doi:10.1006/gyno.2002.6630

Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?

Ayhan A., Taskiran C., Celik C., Guney I., Yuce K., Ozyar E., ...Daha Fazla

GYNECOLOGIC ONCOLOGY, cilt.86, sa.3, ss.259-263, 2002 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 86 Sayı: 3
Basım Tarihi: 2002
Doi Numarası: 10.1006/gyno.2002.6630
Dergi Adı: GYNECOLOGIC ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.259-263
Anahtar Kelimeler: surgical stage I endometrial cancer, survival, adjuvant radiotherapy, morbidity, CLINICAL STAGE, CARCINOMA, ADENOCARCINOMA, LYMPHADENECTOMY, RECURRENCE, MORBIDITY, PATTERNS, SURGERY, FAILURE
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Objective. The aim of this study was to examine the effects of therapeutic modalities on survival of stage I endometrial cancer and also to evaluate the surgical morbidity and the prognostic importance of surgicopathological variables.